PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H0) ("PreveCeutical"), a health sciences company that develops ...
A patient in a clinical trial for a Regenxbio gene therapy developed a brain tumor, leading the FDA to place the study under a clinical hold. This pause has implications for another Regenxbio gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results